Literature DB >> 26062627

Cognitive activity relates to cognitive performance but not to Alzheimer disease biomarkers.

Christopher M Gidicsin1, Jacqueline E Maye1, Joseph J Locascio1, Lesley C Pepin1, Marlie Philiossaint1, J Alex Becker1, Alayna P Younger1, Maria Dekhtyar1, Aaron P Schultz1, Rebecca E Amariglio1, Gad A Marshall1, Dorene M Rentz1, Trey Hedden1, Reisa A Sperling1, Keith A Johnson2.   

Abstract

OBJECTIVE: We aimed to determine whether there was a relationship between lifestyle factors and Alzheimer disease biomarkers.
METHODS: In a cross-sectional study, we evaluated self-reported histories of recent and past cognitive activity, self-reported history of recent physical activity, and objective recent walking activity in 186 clinically normal individuals with mean age of 74 ± 6 years. Using backward elimination general linear models, we tested the hypotheses that greater cognitive or physical activity would be associated with lower Pittsburgh compound B-PET retention, greater (18)F-fluorodeoxyglucose-PET metabolism, and larger hippocampal volume, as well as better cognitive performance on neuropsychological testing.
RESULTS: Linear regression demonstrated that history of greater cognitive activity was correlated with greater estimated IQ and education, as well as better neuropsychological testing performance. Self-reported recent physical activity was related to objective exercise monitoring. However, contrary to hypotheses, we did not find evidence of an association of Pittsburgh compound B retention, (18)F-fluorodeoxyglucose uptake, or hippocampal volume with past or current levels of cognitive activity, or with current physical activity.
CONCLUSIONS: We conclude that a history of lifelong cognitive activity may support better cognitive performance by a mechanism that is independent of brain β-amyloid burden, brain glucose metabolism, or hippocampal volume.
© 2015 American Academy of Neurology.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26062627      PMCID: PMC4501938          DOI: 10.1212/WNL.0000000000001704

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  37 in total

1.  Influence of leisure activity on the incidence of Alzheimer's disease.

Authors:  N Scarmeas; G Levy; M X Tang; J Manly; Y Stern
Journal:  Neurology       Date:  2001-12-26       Impact factor: 9.910

2.  Association of lifetime cognitive engagement and low β-amyloid deposition.

Authors:  Susan M Landau; Shawn M Marks; Elizabeth C Mormino; Gil D Rabinovici; Hwamee Oh; James P O'Neil; Robert S Wilson; William J Jagust
Journal:  Arch Neurol       Date:  2012-05

3.  Leisure activities and the risk of amnestic mild cognitive impairment in the elderly.

Authors:  J Verghese; A LeValley; C Derby; G Kuslansky; M Katz; C Hall; H Buschke; R B Lipton
Journal:  Neurology       Date:  2006-02-08       Impact factor: 9.910

4.  Imaging amyloid deposition in Lewy body diseases.

Authors:  S N Gomperts; D M Rentz; E Moran; J A Becker; J J Locascio; W E Klunk; C A Mathis; D R Elmaleh; T Shoup; A J Fischman; B T Hyman; J H Growdon; K A Johnson
Journal:  Neurology       Date:  2008-09-16       Impact factor: 9.910

5.  The validity of two Omron pedometers during treadmill walking is speed dependent.

Authors:  Dimitra M Giannakidou; Antonis Kambas; Nikolaos Ageloussis; Ioannis Fatouros; Christos Christoforidis; Fotini Venetsanou; Ioannis Douroudos; Kyriakos Taxildaris
Journal:  Eur J Appl Physiol       Date:  2011-04-09       Impact factor: 3.078

6.  Exercise and Alzheimer's disease biomarkers in cognitively normal older adults.

Authors:  Kelvin Y Liang; Mark A Mintun; Anne M Fagan; Alison M Goate; Julie M Bugg; David M Holtzman; John C Morris; Denise Head
Journal:  Ann Neurol       Date:  2010-09       Impact factor: 10.422

7.  Exercise Engagement as a Moderator of the Effects of APOE Genotype on Amyloid Deposition.

Authors:  Denise Head; Julie M Bugg; Alison M Goate; Anne M Fagan; Mark A Mintun; Tammie Benzinger; David M Holtzman; John C Morris
Journal:  Arch Neurol       Date:  2012-05

8.  Molecular, structural, and functional characterization of Alzheimer's disease: evidence for a relationship between default activity, amyloid, and memory.

Authors:  Randy L Buckner; Abraham Z Snyder; Benjamin J Shannon; Gina LaRossa; Rimmon Sachs; Anthony F Fotenos; Yvette I Sheline; William E Klunk; Chester A Mathis; John C Morris; Mark A Mintun
Journal:  J Neurosci       Date:  2005-08-24       Impact factor: 6.167

9.  Cognition, reserve, and amyloid deposition in normal aging.

Authors:  Dorene M Rentz; Joseph J Locascio; John A Becker; Erin K Moran; Elisha Eng; Randy L Buckner; Reisa A Sperling; Keith A Johnson
Journal:  Ann Neurol       Date:  2010-03       Impact factor: 10.422

10.  Amyloid-β associated cortical thinning in clinically normal elderly.

Authors:  J Alex Becker; Trey Hedden; Jeremy Carmasin; Jacqueline Maye; Dorene M Rentz; Deepti Putcha; Bruce Fischl; Douglas N Greve; Gad A Marshall; Stephen Salloway; Donald Marks; Randy L Buckner; Reisa A Sperling; Keith A Johnson
Journal:  Ann Neurol       Date:  2011-03-17       Impact factor: 10.422

View more
  21 in total

Review 1.  Is Alzheimer's Disease Risk Modifiable?

Authors:  Alberto Serrano-Pozo; John H Growdon
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

Review 2.  Detectable Neuropsychological Differences in Early Preclinical Alzheimer's Disease: A Meta-Analysis.

Authors:  S Duke Han; Caroline P Nguyen; Nikki H Stricker; Daniel A Nation
Journal:  Neuropsychol Rev       Date:  2017-05-11       Impact factor: 7.444

Review 3.  Promoting Successful Cognitive Aging: A Ten-Year Update.

Authors:  Taylor J Krivanek; Seth A Gale; Brittany M McFeeley; Casey M Nicastri; Kirk R Daffner
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

4.  Multiple pathways of reserve simultaneously present in cognitively normal older adults.

Authors:  Hwamee Oh; Qolamreza R Razlighi; Yaakov Stern
Journal:  Neurology       Date:  2017-12-22       Impact factor: 9.910

5.  Cognitive reserve and rate of change in Alzheimer's and cerebrovascular disease biomarkers among cognitively normal individuals.

Authors:  Corinne Pettigrew; Anja Soldan; Yuxin Zhu; Qing Cai; Mei-Cheng Wang; Abhay Moghekar; Michael I Miller; Baljeet Singh; Oliver Martinez; Evan Fletcher; Charles DeCarli; Marilyn Albert
Journal:  Neurobiol Aging       Date:  2019-12-17       Impact factor: 4.673

6.  The metabolic brain signature of cognitive resilience in the 80+: beyond Alzheimer pathologies.

Authors:  Eider M Arenaza-Urquijo; Scott A Przybelski; Timothy L Lesnick; Jonathan Graff-Radford; Mary M Machulda; David S Knopman; Christopher G Schwarz; Val J Lowe; Michelle M Mielke; Ronald C Petersen; Clifford R Jack; Prashanthi Vemuri
Journal:  Brain       Date:  2019-04-01       Impact factor: 13.501

Review 7.  Activation of the Brain to Postpone Dementia: A Concept Originating from Postmortem Human Brain Studies.

Authors:  Qiong-Bin Zhu; Ai-Min Bao; Dick Swaab
Journal:  Neurosci Bull       Date:  2019-02-05       Impact factor: 5.203

8.  Cardiorespiratory Fitness Attenuates the Influence of Amyloid on Cognition.

Authors:  Stephanie A Schultz; Elizabeth A Boots; Rodrigo P Almeida; Jennifer M Oh; Jean Einerson; Claudia E Korcarz; Dorothy F Edwards; Rebecca L Koscik; Maritza N Dowling; Catherine L Gallagher; Barbara B Bendlin; Bradley T Christian; Henrik Zetterberg; Kaj Blennow; Cynthia M Carlsson; Sanjay Asthana; Bruce P Hermann; Mark A Sager; Sterling C Johnson; James H Stein; Ozioma C Okonkwo
Journal:  J Int Neuropsychol Soc       Date:  2015-11       Impact factor: 2.892

Review 9.  Microglia and modifiable life factors: Potential contributions to cognitive resilience in aging.

Authors:  Michael R Duggan; Vinay Parikh
Journal:  Behav Brain Res       Date:  2021-02-25       Impact factor: 3.332

10.  Late-Life Physical Activities Moderate the Relationship of Amyloid-β Pathology with Neurodegeneration in Individuals Without Dementia.

Authors:  Bo Kyung Sohn; Min Soo Byun; Dahyun Yi; So Yeon Jeon; Jun Ho Lee; Young Min Choe; Dong Woo Lee; Jun-Young Lee; Yu Kyeong Kim; Chul-Ho Sohn; Dong Young Lee
Journal:  J Alzheimers Dis       Date:  2022       Impact factor: 4.160

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.